Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The Parent Project Muscular Dystrophy (PPMD ... setback is part of the journey toward advancing therapies for Duchenne and Becker, and we draw strength from the resilience and courage of our ...

Senate Appropriations Committee ranking member Patty Murray, D-Wash., wrote in a statement the NIH policy change amounts to ...

A federal judge on Monday prevented the National Institutes of Health from changing the percentage that universities and ...

Research universities, medical schools warn a funding change by the National Institutes of Health could curtail breakthroughs ...

Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...

Results show improved functional outcomes for people with Duchenne muscular dystrophy who are ambulatory. Elevidys, which is ...

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

Santhera Pharmaceuticals will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks, after getting confirmation it will be covered by the NHS in all four nations.

Evan McMenamin said his brother Travis, "never lets it get him down" despite the "incredible challenges" he faces ...